Pretransplant serum FT3 levels in kidney graft recipients are useful for identifying patients with higher risk for graft failure

Clinical Endocrinology

Volumn 68, Issue 2, 2008, Pages 220-225

  Rotondi, Mario ^a   Netti, Giuseppe Stefano ^b   Rosati, Alberto ^c   Mazzinghi, Benedetta ^b   Magri, Flavia ^a   Ronconi, Elisa ^b   Becherucci, Francesca ^b   Pradella, Fabio ^c   Salvadori, Maurizio ^c   Serio, Mario ^b   Romagnani, Paola ^b   Chiovato, Luca ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ARTICLE; FREE LIOTHYRONINE INDEX; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HYPOTHYROIDISM; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECIPIENT; RISK FACTOR; THYROID FUNCTION;

FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TRIIODOTHYRONINE;

EID: 38049096106     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03022.x     Document Type: Article

References (25)

1. Kaptein, E.M. (1996) Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocrine Reviews, 17, 45 63.
2. De Groot, L.J. (1999) Dangerous dogmas in medicine: the nonthyroidal illness syndrome. Journal of Clinical Endocrinology and Metabolism, 84, 151 164.
3. Lo, J.C., Chertow, G.M., Go, A.S. Hsu, C.Y. (2005) Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney International, 67, 1047 1052.
4. Gordois, A., Scuffham, P., Shearer, A. Oglesby, A. (2004) The health care costs of diabetic nephropathy in the United States and the United Kingdom. Journal of Diabetes and its Complications, 18, 18 26.
5. Stadler, M., Auinger, M., Anderwald, C., Kästenbauer, T., Kramar, R., Feinböck, C., Irsigler, K., Kronenberg, F. Prager, R. (2006) Long-term mortality and incidence of renal dialysis and transplantation in type 1 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 91, 3814 3820.
6. Zoccali, C., Tripepi, G., Cutrupi, S., Pizzini, P. Mallamaci, F. (2005) Low triiodothyronine: a new facet of inflammation in end-stage renal disease. Journal of the American Society of Nephrology, 16, 2789 2795.
7. Lebkowska, U., Malyszko, J., Lebkowski, W., Walecki, J. Mysliwiec, M. (2003) Is there any relation between thyroid gland function and kidney transplant function? Transplantation Proceedings, 35, 2222 2223.
8. Rotondi, M., Rosati, A., Buonamano, A., Lasagni, L., Lazzeri, E., Pradella, F., Fossombroni, V., Cirami, C., Liotta, F., La Villa, G., Serio, M., Bertoni, E., Salvadori, M. Romagnani, P. (2004) High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. American Journal of Transplantation, 4, 1466 1474.
9. Solez, K., Benediktsson, H., Cavallo, T., Croker, B., Demetris, A.J., Drachenberg, C., Emancipator, S., Furness, P.N., Gaber, L.W., Gibson, I.W., Gough, J., Gupta, R., Halloran, P., Hayry, P., Kashgarian, M., Marcussen, N., Massy, Z.A., Mihatsch, M.J., Morozumi, K., Noronha, I., Olsen, S., Papadimitriou, J., Paul, L.C., Picken, M. Racusen, L.C. (1996) Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology. Transplantation Proceedings, 28, 441 444.
10. Lazzeri, E., Rotondi, M., Mazzinghi, B., Lasagni, L., Buonamano, A., Rosati, A., Pradella, F., Fossombroni, V., La Villa, G., Gacci, M., Bertoni, E., Serio, M., Salvadori, M. Romagnani, P. (2005) High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. Transplantation, 79, 1215 1220.
11. Kaptein, E.M., Weiner, J.M., Robinson, W.J., Wheeler, W.S. Nicoloff, J.T. (1982) Relationship of altered thyroid hormone indices to survival in nonthyroidal illnesses. Clinical Endocrinology, 16, 565 574.
12. Peeters, R.P., Wouters, P.J., van Toor, H., Kaptein, E., Visser, T.J. Van den Berghe, G. (2005) Serum 3,3′,5′-triiodothyronine (rT3) and 3,5,3′-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. Journal of Clinical Endocrinology and Metabolism, 90, 4559 4565.
13. Zoccali, C., Mallamaci, F., Tripepi, G., Cutrupi, S. Pizzini, P. (2006) Low triiodothyronine and survival in end-stage renal disease. Kidney International, 70, 523 528.
14. Tauchmanova, L., Carrano, R., Musella, T., Orio, F., Sabbatini, M., Lombardi, G., Fenzi, G., Federico, S. Colao, A. (2006) Thyroid function and morphology after a successful kidney transplantation. Journal of Endocrinological Investigation, 29, 625 632.
15. Reinhardt, W., Misch, C., Jockenhovel, F., Wu, S.Y., Chopra, I., Philipp, T., Reinwein, D., Eigler, F.W. Mann, K. (1997) Triiodothyronine (T3) reflects renal graft function after renal transplantation. Clinical Endocrinology, 46, 563 569.
16. Charo, I.F. Ransohoff, R.M. (2006) The many roles of chemokines and chemokine receptors in inflammation. New England Journal of Medicine, 354, 610 621.
17. Hancock, W.W., L.B. Gao, W., Csizmadia, V., Faia, K., King, J.A., Smiley, S.T., Ling, M., Gerard, N.P. Gerard, C. (2000) Requirement of the chemokine receptor CXCR3 for acute allograft rejection. Journal of Experimental Medicine, 192, 1515 1519.
18. Hancock, W.W., Gao, W., Csizmadia, V., Faia, K.L., Shemmeri, N. Luster, A.D. (2001) Donor-derived IP-10 initiates development of acute allograft rejection. Journal of Experimental Medicine, 193, 975 980.
19. Rotondi, M., Chiovato, L., Romagnani, S., Serio, M. Romagnani, P. (2007) Role of chemokines in endocrine autoimmune diseases. Endocrine Reviews, 28, 492 520.
20. Boelen, A., Platvoet-ter Schiphorst, M.C. Wiersinga, W.M. (1993) Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism, 77, 1695 1699.
21. Davies, P.H., Black, E.G., Sheppard, M.C. Franklyn, J.A. (1996) Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness. Clinical Endocrinology, 44, 199 205.
22. Boelen, A., Platvoet-ter Schiphorst, M.C. Wiersinga, W.M. (1995) Soluble cytokine receptors and the low 3,5,3′-triiodothyronine syndrome in patients with nonthyroidal disease. Journal of Clinical Endocrinology and Metabolism, 80, 971 976.
23. Pingitore, A., Landi, P., Taddei, M.C., Ripoli, A., L'Abbate, A. Iervasi, G. (2005) Triiodothyronine levels for risk stratification of patients with chronic heart failure. American Journal of Medicine, 118, 132 136.
24. Napoli, R., Guardasole, V., Angelini, V., Zarra, E., Terracciano, D., D'Anna, C., Matarazzo, M., Oliviero, U., Macchia, V. Saccà, L. (2007) Acute effects of triiodothyronine on endothelial function in human subjects. Journal of Clinical Endocrinology and Metabolism, 92, 250 254.
25. Malyszko, J., Malyszko, J.S., Pawlak, K. Mysliwiec, M. (2006) Possible relations between thyroid function, endothelium, and kidney and liver function in kidney allograft recipients. Transplant Proceedings, 38, 3509 3513.